Lucentis Wet AMD Growth May Cool In 2007, Genentech Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Rapid uptake seen in 2006 is likely to level off this year as patients transition to lower dose frequency, according to the firm.
You may also be interested in...
Genentech Moves To Dampen Avastin Use In Wet AMD By Limiting Sales To Compounding Pharmacists
As of Nov. 30, Avastin can no longer be purchased by compounding pharmacists from wholesale distributors, company announces in "Dear Retinal Community Member" letter.
Genentech Moves To Dampen Avastin Use In Wet AMD By Limiting Sales To Compounding Pharmacists
As of Nov. 30, Avastin can no longer be purchased by compounding pharmacists from wholesale distributors, company announces in "Dear Retinal Community Member" letter.
Herceptin Adjuvant Breast Cancer Sales Slow In First Quarter
Genentech eyes additional opportunities for trastuzumab in adjuvant setting in node-positive, hormone receptor-positive breast cancer patients.